Maximum physical capacity testing in cancer patients undergoing chemotherapy: qualitative findings from an exercise program

Scand J Med Sci Sports. 2006 Dec;16(6):403-11. doi: 10.1111/j.1600-0838.2005.00515.x.

Abstract

Background: Over the past few years there has been a growing interest in the field of physical exercise in rehabilitation of cancer patients, leading to requirements for objective maximum physical capacity measurement (maximum oxygen uptake (VO(2max)) and one-repetition maximum (1RM)) to determine dose-response levels in different cancer diagnoses.

Aim: To explore the patients' experiences of maximum physical capacity testing while concurrently undergoing chemotherapy and participating in a 6-week, 9 h weekly multidimensional exercise program.

Design and method: Prospective, exploratory study using semi-structured qualitative interviews conducted prior to and at termination of the program. The study included 100 patients (18-65 years, median 42 years) with or without residual disease and with mixed diagnoses.

Results: Following the intervention, cancer patients felt significantly safer in performing maximum physical capacity tests as these motivated them through self-perceived competitiveness and set a standard that served to encourage peak performance.

Conclusion: The positive attitudes in this sample towards maximum physical capacity open the possibility of introducing physical testing early in the treatment process. However, the patients were self-referred and thus highly motivated and as such are not necessarily representative of the whole population of cancer patients treated with chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Exercise Tolerance*
  • Exercise*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Motivation
  • Muscle Strength
  • Neoplasms / drug therapy
  • Neoplasms / psychology
  • Neoplasms / rehabilitation*
  • Oxygen Consumption
  • Prospective Studies

Substances

  • Antineoplastic Agents